Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44) - Jun 19, 2015

…

Funding Opportunity Number:	RFA-HL-14-012
Opportunity Category:	Discretionary
Funding Instrument Type:	Grant
Category of Funding Activity:	Health
CFDA Number:	93.233 93.350 93.837 93.838
Eligible Applicants	Small businesses
Agency Name:	HHS-NIH11
Closing Date:	Jun 19, 2015
Award Ceiling:
Expected Number of Awards:
Creation Date:	Apr 16, 2013
Funding Opportunity Description:	The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is to de-risk these technologies so that development can continue with private funding after NHLBI support ends; therefore, applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required.

{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-012.html{/iframe}

Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44) – Jun 19, 2015